ItamarTM Medical Reports Second Quarter 2018 Financial Results

Second Quarter 2018 Highlights:

  • Achieved 20% increase in revenue to a record $6 million
  • Recurring revenue represents 67% of revenue in North America
  • Maintained gross profit of 76% of total revenue
  • Cash basis (non IFRS) operating loss of $0.4 million
  • Board of Directors approved level II American Depositary Receipt